Truist Financial’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$566K Sell
9,637
-1,015
-10% -$42.6K ﹤0.01% 2131
2026
Q1
$343K Sell
10,652
-5,894
-36% -$218K ﹤0.01% 2320
2025
Q4
$697K Sell
16,546
-1,989
-11% -$80.2K ﹤0.01% 1857
2025
Q3
$636K Buy
18,535
+7,528
+68% +$216K ﹤0.01% 1886
2025
Q2
$298K Sell
11,007
-492
-4% -$14.3K ﹤0.01% 2219
2025
Q1
$341K Sell
11,499
-123
-1% -$4.69K ﹤0.01% 2079
2024
Q4
$460K Sell
11,622
-804
-6% -$30.4K ﹤0.01% 1932
2024
Q3
$423K Sell
12,426
-410
-3% -$11.5K ﹤0.01% 1950
2024
Q2
$278K Sell
12,836
-920
-7% -$19.3K ﹤0.01% 2325
2024
Q1
$305K Buy
13,756
+3,336
+32% +$81.4K ﹤0.01% 2282
2023
Q4
$287K Sell
10,420
-552
-5% -$13.3K ﹤0.01% 2327
2023
Q3
$245K Buy
+10,972
New +$282K ﹤0.01% 2356
2022
Q2
Sell
-9,277
Closed -$256K 2783
2022
Q1
$256K Sell
9,277
-887
-9% -$25.4K ﹤0.01% 2405
2021
Q4
$419K Buy
10,164
+175
+2% +$7.73K ﹤0.01% 2124
2021
Q3
$464K Sell
9,989
-8,343
-46% -$364K ﹤0.01% 2050
2021
Q2
$733K Buy
18,332
+1,774
+11% +$75.9K ﹤0.01% 1820
2021
Q1
$890K Buy
16,558
+6,267
+61% +$361K ﹤0.01% 1661
2020
Q4
$503K Sell
10,291
-293
-3% -$13.6K ﹤0.01% 1845
2020
Q3
$344K Buy
10,584
+207
+2% +$6.58K ﹤0.01% 1936
2020
Q2
$269K Buy
10,377
+1,169
+13% +$29.1K ﹤0.01% 2023
2020
Q1
$224K Buy
+9,208
New +$232K ﹤0.01% 2052

Other funds holding VCYT

Truist Financial's VCYT Position: Q2 2026 in Review

Truist Financial reduced its Veracyte (VCYT) stake by 9.5% in Q2 2026, selling an estimated $42.6K and leaving 9,637 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Truist Financial first reported a position in VCYT in Q1 2020 and has held it in 21 quarters since. The position peaked at $890K in Q1 2021. 134 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Truist Financial held 9,637 shares of Veracyte worth $566K as of Q2 2026.
  • Truist Financial sold 1,015 Veracyte shares in Q2 2026, an estimated $42.6K.
  • Veracyte made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2131 holding.
  • Truist Financial first reported a position in Veracyte in Q1 2020 and has held it in 21 quarters since.
  • Truist Financial's Veracyte position peaked at $890K in Q1 2021.
  • 134 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.